The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology—When and Why?
Agnieszka Kaczmarska(Medical University of Lublin), Joanna Zawitkowska(Poznan University of Medical Sciences), Monika Lejman(Medical University of Lublin), Patrycja Śliwa-Tytko(Medical University of Lublin)
Cited by 17
Related Papers
The New Therapeutic Strategies in Pediatric T-Cell Acute Lymphoblastic Leukemia
|International Journal of Molecular Sciences|2021|81
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
|International Journal of Molecular Sciences|2022|74
Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
|International Journal of Molecular Sciences|2022|58
Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia
|Biomedicines|2023|58